These 6 Dividend Stocks Look Like Income Bargains. Their Payout Ratios Say Otherwise

Six stocks are flashing high yields that look like income bargains, but a closer look at their payout ratios tells a very different story about which ones can actually keep the checks coming.

Published October 13, 2026, 9:15am ET · 4 min read

A close-up photograph of a paper financial chart showing blue and red candlestick patterns, along with pink, light blue, and dark blue trend lines. The word 'DIVIDENDS' is written in large, bold black letters across the lower middle of the chart. A black pen with a gold tip lies across the chart, pointing towards the word 'DIVIDENDS'. A dark-colored calculator is partially visible in the blurred background on the upper right.
A financial chart with candlestick patterns and a pen emphasize the importance of dividends for investors seeking income from ETFs. Understanding qualified dividends is key to optimizing after-tax returns. © jittawit21 / Shutterstock.com

A dividend screener flags every company whose payout ran ahead of earnings or cash flow in a given period. That flag is where the work starts. Pfizer (NYSE:PFE | PFE Price Prediction) yields about 6.02% at $28.55, yet its trailing GAAP earnings of $0.77 per share fall well short of its $1.72 annual dividend. Whether that matters depends on why the gap exists. A high yield is only as good as the company’s ability to keep paying it.

Run This Four-Step Test Before Trusting Any Yield

A dividend is unsustainable when the business can’t fund it from cash flow without borrowing or selling assets, year after year. Check in this order:

  1. Use the right earnings base. Strip out non-cash impairments and write-downs. EPS works for ordinary corporates; REITs need FFO/AFFO, MLPs distributable cash flow, BDCs net investment income.
  2. Compare full-year free cash flow to dividends paid. A single quarter can be misleading because of working capital timing.
  3. Look for a disclosed explanation. An acquisition, legal payment, or restructuring charge is a reason. Silence from management is information too.
  4. Check funding and repeat. Is debt rising to fill the gap? Has it happened before? Did the yield climb because the share price gave way?

Ford Motor (F): Explainable Loss, Cyclical Risk

Ford Motor (NYSE:F) pays $0.60 a year, a yield near 4.99% at $12.02. Trailing EPS is -1.88, which trips every screener.

The explanation is on the record. The second-quarter 2026 GAAP loss of $1.33B came from $4.2B in pre-tax special charges, including $3.6B tied to the BlueOval SK joint venture disposition. Adjusted EPS of $0.42 beat the $0.35 estimate, and Ford raised full-year adjusted free cash flow guidance to $6.0 to $7.0B, against roughly $2.35B in annual dividend cash. Steps one and two pass. Step four is shakier: debt-to-equity sits at 4.66, interest coverage at 2.02, Model e is expected to lose about $4.0B this fiscal year, and Ford’s payment record shows a gap after its 2020 payout. A downturn is the real threat.

3M (MMM): Passes the Test

3M (NYSE:MMM) yields just 1.93%, so it barely counts as an income name. Its shortfall happened in 2024, when the quarterly payout dropped from $1.51 to $0.70 after the Solventum spinoff. It has since risen to $0.78.

Adjusted EPS guidance of $8.80 to $8.95 dwarfs the $3.12 forward dividend, and free cash flow guidance of $4.7 to $4.9B compares with about $1.61B in payouts. The open question is litigation: shareholders’ equity fell to $3.0B against $31.9B in liabilities after PFAS and earplug settlements.

Dow (DOW): Already Reset, Now Covered

Dow (NYSE:DOW) halved its quarterly dividend from $0.70 to $0.35 in 2025. It yields about 4.96%, and trailing EPS of -1.84 still looks alarming.

Cash tells a better story. Second-quarter 2026 free cash flow reached $692M against $253M in dividends paid, helped by a 30% jump in polyethylene prices. That dependence is the caveat: shares are up 43.22% over one year but down 34.96% over five, and a cycle rollover would test the reset payout.

Pfizer (PFE): Credible Explanation, Tight Cash

Pfizer’s GAAP gap has a clear cause. The second-quarter 2026 loss of $248M reflected a $3.8B impairment after sigvotatug vedotin failed in Phase 3, plus $867M in legal charges. Adjusted EPS guidance of $2.80 to $3.00 puts the payout near 61% at the low end.

Step two is where coverage looks thin. Pfizer’s free cash flow yield of 5.60% trails its 6.03% dividend yield, and it plans no buybacks in 2026 to preserve cash for deleveraging. Generic competition, a COVID revenue forecast cut from $5B to $4B, and a CFO departure add pressure. Cost savings of $6.7B through 2029 are the path to a safer payout.

Clorox (CLX): Partial Explanation, Real Cash Gap

Clorox (NYSE:CLX) yields about 5.88% at $85, a dividend aristocrat that raised its quarterly payout to $1.25. The yield is largely price-driven: shares fell 25.9% over the past year.

Fiscal 2026 free cash flow of roughly $405M fell short of the roughly $601M dividend expenditure, and the GAAP payout ratio runs near 103%. Management points to the GOJO acquisition and a “value-seeking consumer.” Even so, liabilities rose 48.5% to $7.54B while equity fell to $252M. Fiscal 2027 adjusted EPS guidance of $5.70 to $6.00 must convert to cash.

Whirlpool (WHR): Trap Already Sprung

Whirlpool (NYSE:WHR) shows a trailing yield of 9.37%, and that figure is a mirage. The quarterly dividend fell from $1.75 to $0.90 in 2025, and no common dividend was declared in the second quarter of 2026.

No one-off explains it. Whirlpool posted an ongoing loss of $0.21 per share versus an expected $0.05 profit, revenue fell 6.8%, and it issued $2.0B in secured bonds to clear maturities. Shares are down 59.48% since the end of 2025. Every step of the test fails.

Why the Test Matters More Than the Yield

A one-time charge or acquisition can explain a single bad period. However, repeated shortfalls funded by debt usually can’t. When a dividend does get cut, the share price often drops with it, as Whirlpool shows. Yield alone isn’t a reason to buy, so run the four steps before you trust the payout (we listed seven warning signs that a big yield is about to be cut in a free dividend trap guide if you want a longer checklist).

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →